The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Chronic kidney disease
Open accessAbstract
Chronic kidney disease (CKD) is defined by persistent urine abnormalities, structural abnormalities or impaired excretory renal function suggestive of a loss of functional nephrons. The majority of patients with CKD are at risk of accelerated cardiovascular disease and death. For those who progress to end-stage renal disease, the limited accessibility to renal replacement therapy is a problem in many parts of the world. Risk factors for the development and progression of CKD include low nephron number at birth, nephron loss due to increasing age and acute or chronic kidney injuries caused by toxic exposures or diseases (for example, obesity and type 2 diabetes mellitus). The management of patients with CKD is focused on early detection or prevention, treatment of the underlying cause (if possible) to curb progression and attention to secondary processes that contribute to ongoing nephron loss. Blood pressure control, inhibition of the renin–angiotensin system and disease-specific interventions are the cornerstones of therapy. CKD complications such as anaemia, metabolic acidosis and secondary hyperparathyroidism affect cardiovascular health and quality of life, and require diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Dietary Habits and Risk of Kidney Function Decline in an Urban Population
Liu, Y., Kuczmarski, M. F., Miller, E. R., Nava, M. B., Zonderman, A. B., Evans, M. K., Powe, N. R., & Crews, D. C. (2016) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2016.08.007 · Cited by 47
Glassock, R. J., Fervenza, F. C., Hebert, L. A., & Cameron, J. S. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu077 · Cited by 46
Self-citationDunkler, D., Kohl, M., Teo, K. K., Heinze, G., Dehghan, M., Clase, C. M., Gao, P., Yusuf, S., Mann, J. F. E., & Oberbauer, R. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv086 · Cited by 43
Raschenberger, J., Kollerits, B., Titze, S. I., Köttgen, A., Bärthlein, B., Ekici, A. B., Forer, L., Schönherr, S., Weißensteiner, H., Haun, M., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.020 · Cited by 41
Self-citationFraser, S. D., Aitken, G., Taal, M. W., Mindell, J. S., Moon, G., Day, J., O'Donoghue, D. J., & Roderick, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118676 · Cited by 40
Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells
Takasato, M., & Little, M. H. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6949-4_14 · Cited by 40
Disease Trajectories Before ESRD: Implications for Clinical Management
Sumida, K., & Kovesdy, C. P. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.12.003 · Cited by 38
Weir, M. R., Mayo, M. R., Garza, D., Arthur, S. A., Berman, L., Bushinsky, D. A., Wilson, D. J., & Epstein, M. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001278 · Cited by 37
Stanifer, J. W., Kilonzo, K., Wang, D., Su, G., Mao, W., Zhang, L., La, Z., Nayak‐Rao, S., & Miranda, J. J. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2017.02.005 · Cited by 35
Stem cell therapy for kidney disease
Lazzeri, E., Romagnani, P., & Lasagni, L. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1067300 · Cited by 31
Self-citationIntensified inhibition of renin-angiotensin system: A way to improve renal protection?
Cravedi, P., Ruggenenti, P., & Remuzzi, G. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0078-3 · Cited by 31
Self-citationTonelli, M. A., Agarwal, S. K., Cass, A., García-García, G., Jha, V., Naicker, S., Wang, H., Yang, C.-W., & O'Donoghue, D. J. (2013) · Kidney International · doi:10.1038/ki.2012.488 · Cited by 31
Self-citationAzurmendi, P. J., Fraga, A., Galan, F., Kotliar, C., Arrizurieta, E., Valdez, M. G., Forcada, P. J., Stefan, J. S. S., & Martín, R. S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp136 · Cited by 31
Ruggajo, P., Svarstad, E., Leh, S. M., Marti, H., Reisæter, A. V., & Vikse, B. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153819 · Cited by 29
on behalf of the French REIN registry, de Pinho, N. A., Coscas, R., Metzger, M., Labeeuw, M., Ayav, C., Jacquelinet, C., Massy, Z. A., & Stengel, B. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0492-y · Cited by 28
Self-citationSebille, V., Hardouin, J.-B., Giral, M., Bonnaud‐Antignac, A., Tessier, P., Papuchon, E., Jobert, A., Faurel-Paul, E., Gentile, S., Cassuto, É., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0225-7 · Cited by 27
Plasma Exchange for Kidney Disease: What Is the Best Evidence?
Hildebrand, A. M., Huang, S. S., & Clark, W. F. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.01.008 · Cited by 26
Anguiano, L., Lei, Y., Devarapu, S. K., & Anders, H. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx219 · Cited by 26
Self-citationRecent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis
Li, J., An, C., Kang, L., Mitch, W. E., & Wang, Y. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.03.005 · Cited by 25
Why overestimate or underestimate chronic kidney disease when correct estimation is possible?
Broe, M. E. D., Gharbi, M. B., Zamd, M. A., & Elseviers, M. M. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw267 · Cited by 23
Warnock, D. G., Delanaye, P., & Glassock, R. J. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000455197 · Cited by 22
Self-citationÖzyilmaz, A., Bakker, S. J. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., & for the PREVEND Study Group (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft254 · Cited by 19
Animal models of kidney inflammation in translational medicine
Holderied, A., & Anders, H. (2014) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.06.004 · Cited by 18
Self-citationBecherucci, F., Mazzinghi, B., Provenzano, A., Murer, L., Giglio, S., & Romagnani, P. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0315-4 · Cited by 17
Self-citationKhwaja, A., & Throssell, D. (2009) · Nephron Clinical Practice · doi:10.1159/000235240 · Cited by 16
Levin, A., Lancashire, W., & Fassett, R. G. (2013) · Kidney International · doi:10.1038/ki.2013.91 · Cited by 16
Self-citationA Multidrug, Antiproteinuric Approach to Alport Syndrome: A Ten-Year Cohort Study
Daina, E., Cravedi, P., Alpa, M., Roccatello, D., Gamba, S., Perna, A., Gaspari, F., Remuzzi, G., & Ruggenenti, P. L. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000381480 · Cited by 14
Self-citationScreening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
Taal, M. W. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001345 · Cited by 11
Tonelli, M. A. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.08.035 · Cited by 10
Self-citationBiologic modulation in renal regeneration
Mazzinghi, B., Romagnani, P., & Lazzeri, E. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1219336 · Cited by 3
Self-citation
Cited by
Kellum, J. A., Romagnani, P., Ashuntantang, G., Ronco, C., Zarbock, A., & Anders, H.-J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00284-z · Cited by 1,741
Self-citationAnders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Self-citationTrends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Self-citationKou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., Xu, X., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05034-x · Cited by 640
Metadata
- Authors
- Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-11-23
- Volume
- 3
- Issue
- 1
- Pages
- 17088-17088
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211210745
- Cited by
- 996
- References
- 230
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.